IDEXX Laboratories to Release 2022 Second Quarter Financial Results
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
IDEXX Laboratories, a leader in pet healthcare innovation, will release its 2022 second quarter financial results on August 2, 2022, before market opening. An analyst conference call is scheduled for 8:30 a.m. ET on the same day.
A live webcast will be accessible via the IDEXX website, with an archived version available post-event for one year. This event illustrates IDEXX's ongoing commitment to transparency and investor engagement, following their track record in diagnostic and software solutions that benefit veterinary practices globally.
Positive
- Scheduled release of Q2 results indicates ongoing transparency with investors.
Negative
- None.
Details
News Market Reaction – IDXX
The recorded move for IDXX in the trading session of this news was -1.06%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WESTBROOK, Maine, July 8, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2022 second quarter results for Tuesday, August 2, 2022 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Individuals can access a live webcast of the conference call through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year.
The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-866-374-5140 or 1-404-400-0571 and reference pin 28182746.
About IDEXX Laboratories
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in Maine, IDEXX employs more than 10,000 people and offers solutions and products to customers in more than 175 countries. For more information about IDEXX, visit idexx.com.
Contact:
Investor Relations:
investorrelations@idexx.com
207-556-8155
View original content to download multimedia:https://www.prnewswire.com/news-releases/idexx-laboratories-to-release-2022-second-quarter-financial-results-301583120.html
SOURCE IDEXX Laboratories, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
